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Introduction
Following administration, drugs are absorbed, distributed, metabolized and then eliminated.
Usually, a fraction of the drugs administered are eliminated in unchanged form. However, in many cases, drugs are metabolized to increase their hydrophilic properties prior to elimination.
Drug metabolism reactions are categorized into phase I and II reactions. Oxidation, reduction and hydrolysis are categorized as a phase I reactions. On the other hand, conjugations are categorized as Phase II reactions. In phase I reactions, P450 cytochromes (P450, CYPs) play a key role (Guengerich, 2006) . However, regarding conjugation reactions, glucuronidation contributes to approximately 35% of phase II reactions (Evans and Relling, 1999) .
UDP-Glucuronosyltransferases (UGTs, Ugts) catalyze glucuronidation and the classical view that P450-catalyzed hydroxylations precede glucuronidation of the metabolites formed by P450 holds true for many drugs. However, compounds such as morphine are cleared primarily by direct glucuronidation without requiring P450 enzymes (Yoshimura et al., 1969) . Further, UGTs occupy 2 nd place after P450 in terms of drug clearance (Williams, et al., 2004) . Thus, it is important to investigate UGT-catalyzed reactions.
The use of morphine to treat pain associated with cancer is widely recommended (World Health Organization, 1996) . However, there is also an accompanying issue of morphine overdosing and considerable numbers of patients medicated with morphine die (Okie, 2010) . It is glucuronidated in vivo to form a main metabolite, morphine-3-glucuronide (M-3-G), and a minor metabolite, morphine-6-glucuronide (M-6-G) (Yoshimura et al., 1969) . Although M-3-G is a non-analgesic metabolite, M-6-G is a more potent metabolite than the parent morphine (Shimomura et al., 1971) . It is known that there are species differences in M-6-G formation. A JPET #240382 5 relatively large amount of M-6-G is formed in humans and guinea pigs after morphine treatment while only a small amount of M-6-G is formed in rats and mice (Oguri et al., 1970; Svensson et al., 1982; Kuo et al., 1991) . In humans, UGT2B7 mainly catalyzes the formation of M-3-G and M-6-G (Coffman et al., 1997; Stone et al., 2003) while, in guinea pigs, UGT2B21 catalyzes M-3-G formation (Ishii et al., 2001) . In rats, UGT2B1 catalyzes M-3-G formation (Pritchard et al., 1994) . In mice, Ugt2b1 is considered as orthologous to rat UGT2B1 on the basis of sequence similarity (Mackenzie et al., 2005) . However, its function has yet to be characterized. Although it is reasonable to suppose that the mouse Ugt involved in morphine glucuronidation probably belongs to the Ugt2b subfamily, mouse Ugt isform(s) involved in morphine glucuronidation are so far unknown. Since the mouse is a very important experimental animal, it is expected that characterization of the Ugt isoform(s) involved in morphine metabolism will help in the extrapolation of pre-clinical trial data to humans.
To date, there are 21 Ugt isoforms known to be expressed in mice which belong to the Ugt1a, 2a, 2b and 3a subfamilies (Mackenzie et al., 2005) . These are mainly expressed in the liver and intestine but, in some cases, in brain and lung (Buckley and Klaassen, 2007) . The gene structure of the UGT1A subfamily involves a variable exon 1 and common exons 2 to 5 (Iyanagi, 1991; Ritter et al., 1992) . The UGT1 locus consists of variable first exons and four shared exons in a tandem array. Since such gene structures are to a degree conserved among mouse, rat and human, at least, Ugt1a1 and 1a6 in mice seem orthologous to UGT1A1 and 1A6 in humans and rats, respectively (Mackenzie et al., 2005) . This is supported by a study using Ugt1a locus null-mice (Nguyen et al., 2008) . However, for the mouse Ugt2b subfamily, all Ugt2b isoforms except Ugt2b1 have unique numbers since it is difficult to define orthologues. There are many studies JPET #240382 6 of changes in the expression level of Ugt isoforms in mice involving disease, chemicals or genetically-engineered model animals (Buckley and Klaassen, 2007; 2009a; 2009b; Lu et al., 2010) . Further, knocking out the Ugt2b locus in mice has been reported and characterized (Fay et al., 2015) . However, characterization of mouse Ugt isoforms, except 1a6 (Uchihashi et al., 2012; 2013) , has not been reported and it would be of great interest to understand the function of mouse Ugts, especially the Ugt2b subfamily.
In this study, with reference to a mouse genome database, we have cloned cDNAs encoding all Ugt isoforms belonging to the Ugt2b subfamily and established their expression system. We found that Ugt2b36 is the predominant morphine Ugt in mice.
Materials and Methods
Chemicals
Morphine hydrochloride was purchased from Takeda Pharmaceutical Industry, Co., Ltd. (Osaka, Japan). 4-Methylumbelliferone (4-MU), estradiol 3β-D-glucuronide (E3G), estradiol 17β-D-glucuronide (E17G) and alamethicin were purchased from Sigma-Aldrich (St. Louis, MO Pharmaceutical Sciences, Tokushima Bunri University, Japan). M-3-G was synthesized by a method described previously (Yoshimura et al., 1968) . All other reagents were of the highest grade commercially available.
RNA Extraction and Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted from male mouse-liver tissue using an RNeasy® Mini Kit (QIAGEN, Hilden, Germany) and the RNA was quantified by absorbance at 260nm. cDNA was prepared from 250 µg total RNA in 15 µL of total volume using a Primescript™ RT Reagent Kit (Takara Bio, Shiga, Japan).
Amplification and cloning of cDNAs encoding mouse Ugt isoforms
PCR primers were designed to amplify cDNAs encoding mouse Ugt isoforms based on the genome database. The GeneBank accession numbers of the reference sequences are as follows:
JPET #240382 8 (AAH28262) (Kimura and Owens, 1987) , Ugt2b34 (EDL37970), Ugt2b35 (AAI13790), Ugt2b36 (AAI41233), Ugt2b37 (AAH29487), and Ugt2b38 (AAH69923). The primers used are listed in Table 1 , and the PCR conditions are described ( Supplemental Tables 1 and 2 ). The PCR products were extracted from agarose gels and purified using a QIAquick® Gel Extraction Kit (QIAGEN).
Purified PCR products with restriction sites at both ends were digested in NotI and XhoI, then cloned into pFastBac1 restricted with the same enzymes. The sequencing reaction was carried out using a Big Dye® Terminator v3.1 Cycle Sequencing Kit (Life Technologies). Then, cDNA sequences were confirmed by an ABI 3130xl Genetic Analyzer. There were only non-synonymous mutations in Ugt1a1 (T915G) and Ugt2b5 (G693A) on the basis of the reference sequences (Kong et al., 1993; Kimura and Owens, 1987) . The sequences of the other Ugt-cDNAs amplified were identical to each reference. Therefore, all the Ugt cDNAs amplified in this study were regarded as wild-type.
Expression of Recombinant Ugts
Bacmid of the recombinant Ugts was prepared from Escherichia coli DH10Bac™ strain (Life Technologies)-transformed with recombinant pFastBac1. Recombinant baculovirus was prepared using the Bac-to-Bac® Baculovirus Expression System (Life Technologies) as described previously (Ishii et al., 2014) . The amplification of baculovirus was repeated usually two-to three-times to obtain the virus with a titer of over 1.0 x 10 7 plaque-forming units/ml. (2014) . Preparation of recombinant UGT2B7 baculovirus was described previously (Miyauchi et al., 2015; Jin et al., 1993) . The UGT2B7 baculosomes used in this study were prepared similarly to the mouse Ugt2b isoforms as described above.
Immunoblotting
Microsomes separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) were electroblotted on a polyvinyldene difluoride (PVDF) membrane (Millipore, Bedford, MA). Each of the Ugts was detected using goat anti-mouse low-pI formed UGT antibody (Mackenzie et al., 1984) or rabbit anti-UGT2B antibody (Kasai et al., 2004) . As secondary antibodies, horseradish peroxidase (HRP)-rabbit anti-goat IgG (MP Biomedicals, Santa Ana, CA) and HRP-donkey anti-rabbit IgG (GE Healthcare, Little Chalfont, UK) were used. Clarity™ Western ECL Substrate (Bio-Rad, Hercules, CA) was used as the substrate of HRP, and the chemiluminescence emitted was analyzed using a ChemiDoc™ MP System (Bio-Rad, Hercules, CA).
Endoglycosidase H (EndoH)-treatment
Treatment of baculosomes with EndoH was performed as described previously (Nakamura et al., 2016) . 
Glucuronidation Assay
The glucuronidation of morphine at the 3-hydroxyl group was carried out by a method reported previously (Nurrochmad et al., 2010) The 4-MU glucuronidation activity and glucuronidation of 17β-estradiol at the 3-and 17-hydroxyl groups were determined by the method described previously (Nishimura et al., 2007) were dissolved in methanol, and the final concentration of methanol in the incubation mixture was 0.5%. Incubation was performed at 37ºC for 1 hr and the glucuronides were detected by HPLC. The eluted solution of 4-MU was prepared by mixing eluent A (20 mM sodium phosphate, pH 2.2) and eluent B (acetonitrile): the concentration of acetonitrile was 20% for 9.9 min, then increased to 50% for 0.1 min, held at 50% for 3 min and, finally, reduced to 20% and held there for 7 min. The flow rate was set at 0.8 ml/min. 4-MU-glucuronide was quantified by fluorescence detection (excitation 315 nm and emission 375 nm). Under these conditions, the retention time of 4-MU-glucuronide was 5.1 min. For detection of 17β-estradiol-3-glucuronide (E3G) and 17-glucuronide (E17G), a solution mixing eluent A (20 mM sodium phosphate, pH 2.2) and eluent B (acetonitrile) was prepared: the concentration of acetonitrile was 35% for 19.9 min, then increased to 60% for 0.1 min, held at 60% for 5 min and, finally, reduced to 35% and held there for 5 min. Then, the column was equilibrated with the initial condition before analysis of new sample. The flow rate was set at 1 ml/min. E3G and E17G were quantified by fluorescence detection (excitation 210 nm and emission 300 nm). Under these conditions, the retention times of E3G and E17G were 3.9 and 4.6 min, respectively. In kinetic assays for estradiol, the substrate concentration was varied ranging from 1 to 100 µM. For MLM and Ugt1a1-expressing microsomes, 100 µg protein was used. Incubation was performed at 37˚C for 1h. the concentration of acetonitrile was 20% for 9.9 min, then increased to 50% for 0.1 min, held at 50% for 7 min and, finally, reduced to 20% and held there for 3 min. The flow rate was set at 0.8 ml/min and the retention time of chloramphenicol glucuronide under these conditions was 11.6 min.
Construction of a phylogenetic tree of mouse Ugts and the UGTs in other species
The amino acid sequences of mouse Ugts examined in this study were compared with those of human UGT amino acids. In addition, rat (rattu norvegicus) UGT2B1 (Mackenzie, 1987) and guinea pig UGT2B21 (BAB82476). A distance-based neighbor-joining phylogenetic tree was generated (Saitou and Nei, 1987) . The reliability of the phylogeny was tested by bootstrap analysis with 1000 replicates. The bootstrap values are indicated in the neighbor-joining 
Data Analysis
Data analysis for the kinetics was carried out using GraphPad Prism 5.04 software (GraphPad software, La Jolla, CA). Kinetic data were fitted to a Michaelis-Menten model using the equation below:
where V is the reaction rate, Vmax is the maximum enzyme velocity, S is the substrate concentration, and Km is the substrate concentration giving half Vmax.
In the case of UGT2B7, the kinetic data were fitted to a sigmoidal model defined by the equation below:
where S 50 is the substrate concentration giving half Vmax, and n is the Hill coefficient.
Other Method
This article has not been copyedited and formatted. The final version may differ from this version. 
Results
The substrate specificities of the Ugt2b subfamily mouse isoforms were studied. cDNAs encoding all the mouse Ugt2b subfamily isoforms were amplified by nested RT-PCR from mouse liver mRNA. Ugt1a1 and 2a3 cDNA were also cloned and expressed by the baculovirus-Sf9 system. Their microsomes were prepared and the expression of these Ugt proteins was confirmed by western blotting using an antibody toward a low-pI mouse Ugt (Fig.   1A ). Although we carried out the expression of Ugts under the same conditions, the intensity of bands varied, possibly due to differences in immuno-reactivity between isoforms. Thus, we compared the Ugt content in microsomes by use of an anti-peptide antibody which recognizes the same epitope in all the mouse Ugts examined in this study (Fig. 1B) . The antibody was originally produced against a common epitope (KWIPQNDLLGHPK; the residues 355-367 of UGT2B7) of human UGT2B isoforms (Supplemental With the exception of Ugt2b35, all mouse Ugt2b forms as well as Ugt1a1 and Ugt2a3 appeared as a single band on SDS-PAGE (Fig. 1A) . In case of Ugt2b35, the microsomes were treated with EndoH prior to SDS-PAGE ( Fig. 1B) . Thus it was possible to normalize the relative Ugt content in the microsomes expressing each mouse Ugt isoform when evaluating their catalytic property.
Using 4-MU as a substrate, all the Ugt isoforms examined exhibited activity. However, substrate preferences differed among isoforms. With 4-MU, very high activity was observed for Ugt2b5, Ugt2b34, 2b36 and Ugt1a1 whereas Ugt2b1 and 2b35 showed intermediate activity and
Ugt2b37, 2b38 and 2a3 exhibited much lower activity (Fig. 2) . Glucuronidation of steroids is typical of UGT isoforms. We used 17β-estradiol which possesses both an aromatic 3-hydroxyl group and a 17β-hydroxyl group as a substrate. Keeping the substrate concentration at 1 mM, we examined which isoform(s) is mainly involved in the glucuronidation of this steroid. Of the Ugt isoforms examined in this study, Ugt1a1 is the main catalyst for glucuronidation at the 3-hydroxyl group (Fig. 3) . Although there were measurable activities for the other isoforms, these were far lower than that of Ugt1a1. In addition, their specificities for the 17β-hydroxyl group were significantly different ( Fig. 3) . At 1 mM 17β-estradiol, Ugt2b5 exhibited high activity followed by Ugt2b1 which also exhibited considerable activity, while Ugt2b34, 2b35, 2b38 and 2a3 exhibited lower activity. However, the activities of Ugt2b36, 2b37 and 1a1 were below the detection limit. Also, at 10 µM 17β-estradiol, Ugt2b34, 2b35, 2b38 and 2a3 did not have any substantial activity with regard to the 17-hydroxyl group. Ugt2b5 exhibited high activity followed by Ugt2b1 at a low substrate condition as well.
For glucuronidation of morphine, Ugt2b36 exclusively catalyzed this reaction while Ugt2b34, 2b35 and 2b37 exhibited very low activity (Fig. 4A) . Also, no activity was detected for Ugt2b1, 2b5, 2b38, 1a1 and 2a3. Under the assay conditions used, Ugt2b36 only catalyzed glucuronidation at the 3-hydroxyl group of morphine (M-3-G formation) but not at the 6-hydroxyl group (M-6-G formation). Glucuronidation of chloramphenicol was catalyzed only by Ugt2b1 and 2b5 (Fig. 4B) , with Ugt2b5 exhibiting the higher activity. The other isoforms examined in this study showed no substantial activity with regard to chloramphenicol.
In the kinetic study, Ugt2b36 microsome-catalyzed morphine glucuronidation was fitted to a Michaelis-Menten equation similar to that of MLM ( Fig. 5A , Table 2 ) while human UGT2B7, the predominant isoform participating in hepatic morphine glucuronidation, exhibited sigmoidal kinetics ( Fig. 5C , Table 2 ). Again, the Vmax of MLM was higher than that of Ugt2b36, but it cannot be simply compared because the Ugt2b36 content was not normalized between MLM and the Ugt2b36-expressing microsomes. However, the Kms of Ugt2b36 and MLM for morphine were comparable. The Km of Ugt2b36 was lower than that of UGT2B7 while the intrinsic clearance of Ugt2b36 was higher than that of UGT2B7. It is reasonable to suppose that Ugt2b36 is a representative isoform involved in morphine glucuronidation in mouse liver. On the basis of the expressed enzymes in this study, mouse Ugt2b36 exhibits higher activity than human UGT2B7. Regarding the kinetics of estradiol 3-glucuronidation activity, Ugt1a1 and MLM were examined (Fig. 6, Table 3 ). Again, the Vmax of MLM was higher than that of Ugt1a1, but it cannot be simply compared because the Ugt1a1 content was not normalized between MLM and the Ugt1a1-expressing microsomes. However, the Km of Ugt1a1 for the 3-hydroxyl group of estradiol was smaller than MLM. This suggested that glucuronidation at the 3-hydroxyl group of estradiol was catalyzed by Ugt1a1.
Discussion
There are a number of reports describing changes in the level of mouse Ugt isoforms depending on gender, disease or chemicals (Buckley and Klaassen, 2007; 2009a; 2009b) . the intensity of the Ugt bands varied (Fig. 1A) . Therefore, we evaluated relative Ugt levels with an anti-UGT2B antibody which recognizes all the mouse Ugt2b subfamily isoforms, Ugt1a1 and Ugt2a3 to a comparable extent (Fig. 1B) . This enabled normalization of the Ugt activity on the , 1994) . Furthermore, this is also supported by the phylogenetic tree in this study (Supplemental Fig. 1 ). It is reasonable to suppose that mouse Ugt2b1 and rat UGT2B1 are orthologues. However, mouse Ugt2b1 did not show any substantial activity toward morphine (Fig. 4) . Therefore, care should be taken in discussing the function of Ugt isoforms, especially a candidate orthologue such as mouse Ugt2b1 prior to characterizing function. For human UGT2B7, it has been shown that Asp99 is important for the binding of morphine (Coffman et al., 2003) . In rat UGT2B1, the residue is conserved as Asp100 and there are 37 amino-acid differences between them. Therefore, it is assumed that these differences resulted in the different substrate specificity of mouse Ugt2b1 from rat UGT2B1. The amino acids sequences in the N-terminal half of UGTs have been considered to be important for substrate binding. However, the details remain to be clarified.
Data from the kinetic analysis showed that the Km of mouse Ugt2b36 is lower than that of UGT2B7 which is a predominant UGT catalyzing morphine glucuronidation in human liver.
Thus, it seems that Ugt2b36 exhibits higher affinity for morphine than UGT2B7. Furthermore, the Vmax of Ugt2b36 was approximately 5-times higher than that of UGT2B7. Thus, the intrinsic clearance of Ugt2b36 was 17-times higher than that of UGT2B7. However, the expression level of UGT2B7 in Sf9 microsomes used in this study has not been accurately determined. The Km of UGT2B7 in COS cell microsomes (Takeda et al., 2005) was comparable with that of Ugt2b36 in this study. This suggests that Ugt2b36 exhibits higher glucuronidation activity toward morphine than UGT2B7. However, since there are differences in the expression systems, we cannot conclude that there are definitive differences. Also, there is a report that the relative morphine-glucuronidation activities of human liver microsomes (HLM) and MLM were 1 : 64 (Higashi et al., 2014) . Therefore, this strongly suggests that both Ugt2b36 and UGT2B7 are predominant UGT isoforms in mouse and human livers, respectively. Mouse Ugt2b36 is mainly expressed in the liver but the level is quite low in other tissues (Buckley and Klaassen, 2007) . The hepatic ontogeny of Ugt mRNA of mice has been reported (Lu et al., 2013) . Mouse
Ugt2b36 is expressed as one of the major isoforms in the fetus, then reduced at birth, but increased to be a predominant isoform again in the liver at puberty and in adulthood (Lu et al., 2013) . Taking these findings into consideration, mouse Ugt2b36 is a predominant isoform JPET #240382 20 participating in morphine glucuronidation in the liver.
There were multiple bands in the Ugt2b35 preparation examined in this study while the other Ugts examined in this study were expressed as an apparent single band (Fig. 1A) . Therefore, we carried out the EndoH digestion on Ugt2b35 ( Supplemental Fig. 2) to determine the cause of this multiple banding. It is evident that Ugt2b35 in the preparation is glycosylated. There are three potential N-glycosylation-sites in Ugt2b35. The lower and higher bands (Fig. 1A) are probably differently glycosylated forms. Ugt2b35 exhibited considerable activity toward the universal substrate 4-MU. Since the Ugt2b35 preparation used in this study consisted of a relatively high amount of the lesser glycosylated form, we cannot exclude the possibility that the multiple-glycosylated form shows higher activity. In addition, glycosylation of Ugt2b36 was not obvious (Supplemental Fig. 2 ). We carried out the expression of Ugt carefully and most Ugt isoforms except Ugt2b35 are expressed as a single band on SDS-PAGE gels. A previous report suggested that transfection with high amounts of virus results in the production of inactive UGT (Zhang et al., 2012) . In consideration of this, we used low MOI and the shorter durations of transfection so that it is reasonable to suppose that the Ugt isoforms examined in this study are expressed properly as demonstrated by their substantial glucuronidation activity toward the universal substrate 4-MU. Again, Ugt2b37 also exhibits substantial activity toward 4-MU. Better substrates for Ugt2b35 and 2b37 are yet to be identified.
Regarding estradiol glucuronidation, glucuronidation at the 3-hydroxyl group is seen as a marker activity of human UGT1A1 (Senafi et al., 1994; Court 2005) . Similarly, in mice, Ugt1a1 exhibits high activity at the 3-hydroxyl position of estradiol but not at the 17-hydroxyl group (Figs. 3 and 6 ). Glucuronidation at the 17-hydroxyl group was also catalyzed by Ugt2b1, 2b5, 2a3, 2b34, 2b35 and 2b38 (Fig. 3) . However, Ugt2a3, 2b34, 2b35 and 2b38 did not exhibit any significant activity at the lower concentration (10 µM). This suggests that Ugt2b5 and 2b1 are important under physiological conditions. In humans, UGT2B15 and 2B17 are predominant catalysts of 17β-hydroxysteroid glucuronidation (Beaulieu et al., 1996) . Therefore, it is reasonable to suppose that, in mice, Ugt2b1 and 2b5 are functional orthologues of human UGT2B15 and 2B17. Also, mouse Ugt2b1 and 2b5 are the major isoforms expressed in adults (Lu et al., 2013) . Therefore, mouse Ugt2b1 and 2b5 seem to play important roles in the glucuronidation of 17β-hydroxysteroids in the adult.
Ugt2b1 and 2b5 exclusively catalyze chloramphenicol glucuronidation (Fig. 4B ) while the other isoforms examined did not. Chloramphenicol is known to be a substrate for rat UGT2B1 (Mackenzie, 1987) . Therefore, the substrate specificity of Ugt2b1 was somewhat conserved for Although the catalytic properties of other substrates are also important, this study provides a comprehensive characterization of Ugt2b subfamily isoforms in mice using typical substrates.
The data obtained suggest that Ugt2b36 is a predominant isoform involved in morphine glucuronidation in mouse liver. Furthermore, typical isoforms involved in estradiol and chloramphenicol glucuronidation were identified. Further studies are necessary to interpret the Baculosomes (10 µg protein) from Ugt2b5-expressing Sf-9 cells were electrophoresed (7.5% SDS-PAGE). For other baculosomes, amounts of protein were used that were comparable to the Ugt content in the Ugt2b5. For Ugt2b35, the sample was treated with EndoH according to Nakamura et al. (2016) prior to subject to the SDS-PAGE. Then, those were electrophoretically transferred to PVDF membrane. Ugts were detected by anti-UGT2B antibody (Kasai et al., 2004) as the primary antibody. Details are described in Materials and Methods. 
Fig. 2. Comparison of the glucuronidation activity of each mouse Ugt isoform toward
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